A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

The Road Safety Directing Center has called for stricter local enforcement to reduce accidents and drunk driving during the ...

In one very small study, an anti-diarrhea drug called Detoxsan containing ... and fibers Interactions with antibiotics, chemotherapy drugs, immune-suppressing drugs, or other medicines that ...

Exercise is a powerful modulator of gut health in patients with gastrointestinal (GI) conditions, as moderate activity can ...

The tablet is not entirely safe to consume on a regular basis unless under the supervision of a physician. Side effects ...

In addition to meeting the primary endpoint of superior A1C reduction, the once-daily oral pill reduced weight by an average ...

The University of Central Lancashire is co-leading the first and largest human trial of its kind. A study found that patients ...